Advanced search×

Application of a novel automatic duration method measurement based on the wavelet transform on pathological motor unit action potentials

Clin Neurophysiol 121(9):10 (2010) PMID 20427231

Objective: To evaluate a recently published automatic duration method based on the wavelet transform applied on normal and pathological motor unit action potentials (MUAPs). Methods: We analyzed 313 EMG recordings from normal and pathological muscles during slight contractions. After the extraction procedure, 339 potentials were accepted for analysis: 68 from normal muscles, 124 from myopathic muscles, 20 from chronic neurogenic muscles, 83 from subacute neurogenic muscles and also 44 fibrillation potentials, as an example of very low duration muscular potentials. A ''gold standard'' of the duration positions (GSP) was obtained for each MUAP from the manual measurements of two senior electromyographists. The results of the novel method were compared to five well-known conventional automatic methods (CAMs). To compare the six methods, the differences between the automatic marker positions and the GSP for the start and end markers were calculated. Then, for the different groups of normal and pathological MUAPs, we applied: a one-factor ANOVA to compare their relative mean differences, the estimated mean square error (EMSE) and a Chi-square test about the rate of automatic marker placements with differences to the GSP greater than 5ms, taken as gross errors. Results: The mean and the standard deviation of the differences, the EMSE and the gross errors for the novel method were smaller than those observed with the CAMs in the five different MUAP groups and significantly different in most of the cases. Conclusions: The novel automatic duration method is more accurate than other available algorithms in normal and pathological MUAPs. Significance: Accurate MUAP duration automatic measurement is an important issue in daily clinical practice.

DOI: 10.1016/j.clinph.2010.03.028
Version: za2963e q8za4 q8zbe q8zc1 q8zdf q8zef q8zf2 q8zga

Similar articles you may find interesting…

  1. A tyrosinase biosensor based on ordered mesoporous carbon-Au/l-lysine/Au nanoparticles for simultaneous determination of hydroquinone and ca...

    Analyst (2013) PMID 23671910

    A novel biosensor was developed based on tyrosinase immobilization with ordered mesoporous carbon-Au (OMC-Au), l-lysine membrane and Au nanoparticles on a glassy carbon electrode (GCE). It was applied for the simultaneous determination of dihydroxybenzene isomers using differential p...
  2. Liquid chromatography-tandem mass spectrometric assay for aliskiren, a novel renin inhibitor in micro-volumes of human plasma: a pharmacokin...

    Biomed Chromatogr (2013) PMID 23649371

    This paper describes a simple, rapid and sensitive liquid chromatography/tandem mass spectrometry assay for the determination of aliskiren in human plasma using nevirapine as an internal standard. Analyte and the internal standard were extracted from 100 μL of human plasma via liqui...
  3. PEP-1-CAT protects hypoxia/reoxygenation-induced cardiomyocyte apoptosis through multiple sigaling pathways.

    J Transl Med 11(1):113 (2013) PMID 23642335

    PEP-1-CAT protected H9c2 from H/R-induced morphological alteration and reduced the release of lactate dehydrogenase (LDH) and malondialdehyde content. Superoxide anion production was also decreased. In addition, PEP-1-CAT inhibited H9c2 apoptosis and blocked the expression of apoptosis stimulator Ba...